LEGN
Legend Biotech Corp
19.30$
-2.9%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -17.2% | +18.3% | +98.4% | -14.1% | +16.4% | +4.6% | +30.8% | +6.8% | +12.5% | -0.4% | +27.0% | – | |
| – | -33.3% | +68.7% | -7.8% | +9.9% | +33.3% | -3.5% | +37.4% | +17.7% | +7.1% | +42.5% | -21.9% | – | |
| – | -0.7% | -16.5% | +246.7% | -23.0% | +7.5% | +9.9% | +27.0% | 0.0% | +16.5% | -29.4% | +93.6% | – | |
| – | +10.3% | -4.5% | +11.6% | -15.2% | +9.3% | -2.4% | -3.6% | +15.1% | -10.4% | -15.2% | +11.7% | – | |
| – | +2.1% | +11.2% | +10.7% | -0.1% | -3.1% | -8.0% | +3.6% | +6.5% | +6.6% | +8.0% | -17.5% | – | |
| – | +19.3% | -5.8% | +13.3% | -1.8% | +7.0% | -6.8% | +2.6% | +12.0% | +1.5% | -12.0% | +7.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.5% | -5.9% | +0.2% | +0.4% | -6.4% | -1.8% | +3.5% | +7.7% | -2.9% | +0.3% | -96.4% | – | |
| – | – | – | – | – | – | -344.7% | – | – | – | – | – | – | |
| – | – | – | +4,420.0% | +1,862.4% | +220.8% | -87.4% | -67.4% | +5.8% | +1,720.8% | -89.3% | +1,758.3% | – | |
| – | – | – | – | – | – | -483.9% | – | – | – | – | – | – | |
| – | – | – | – | – | – | -269.4% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.